Skin cancer rarely appears out of nowhere, even when it feels that way. Most skin cancers develop over months to years through cumulative DNA damage in skin cells, but they often go unnoticed until a visible lesion crosses a threshold that catches your eye. The exception is a handful of aggressive subtypes that genuinely grow fast, sometimes changing week to week. Understanding the difference between “suddenly noticed” and “suddenly formed” is one of the most practical things you can learn about skin cancer.
Most Melanomas Do Not Come From Existing Moles
One of the most common assumptions is that melanoma starts as a mole that turns cancerous. The reality is more complicated. Roughly 70% of cutaneous melanomas arise de novo, meaning they appear on previously normal-looking skin with no identifiable precursor lesion. The remaining fraction, up to about 30%, does develop from a pre-existing mole, though reported rates vary widely depending on the study and how closely the tissue is examined under a microscope.1PubMed Central. Prognostic Value of Nevus-Associated Melanoma in Patients with Melanoma This means that checking only your existing moles misses the majority of melanomas. The new spot that was not there six months ago deserves just as much attention as the old one that changed shape.
Having many moles does increase your overall risk of melanoma, and certain atypical moles raise that risk further.2PubMed Central. Melanoma risk factors and atypical moles But the takeaway is not that moles inevitably become cancer. It is that melanoma can emerge on any patch of skin, whether or not there was a mole there before, and the de novo path is actually the more common one.
The Slow Buildup You Cannot See
Even when a skin cancer seems to pop up suddenly, the underlying damage has usually been accumulating for years. Ultraviolet light from the sun causes DNA lesions in skin cells almost instantly, and in pigment-producing cells the damage continues forming for up to three hours after UV exposure ends, driven by reactive molecules interacting with melanin.3PubMed Central. Deciphering UV-induced DNA Damage Responses to Prevent and Treat Skin Cancer Most of these lesions get repaired by the cell’s built-in maintenance systems. But over decades of sun exposure, some mutations slip through and persist.
When enough mutations accumulate in the right genes, a cell can begin dividing abnormally. Research comparing healthy skin, benign moles, and melanomas from the same patients has shown that the mutation burden rises progressively from normal tissue to benign moles to full-blown tumors. Certain driver mutations, particularly in growth-signaling pathways, appear early and are shared between moles and the melanomas that later develop from them, providing evidence that the cancer evolved step by step.4PubMed Central. Genetic Evolution of Melanoma: Comparative Analysis of Candidate Gene Mutations in Healthy Skin, Nevi, and Tumors from the Same Patients Additional mutations in tumor-suppressor genes then push the lesion from benign to malignant. The whole process can take years without producing anything visible on the surface.
For non-melanoma skin cancers, a similar slow timeline applies. Actinic keratoses, those rough, scaly patches that show up on sun-damaged skin, are precursors to squamous cell carcinoma. In one study tracking patients who had a confirmed actinic keratosis at a specific site and later developed squamous cell carcinoma at that same location, the average progression time was about two years.5PubMed. The kinetics of skin cancer: progression of actinic keratosis to squamous cell carcinoma That is not instant, but it is not decades either, and plenty of people ignore rough patches for far longer than two years.
Field Cancerization and Why Skin Cancers Can Cluster
If you have had one non-melanoma skin cancer on a chronically sun-exposed area like your scalp, forearms, or face, you may have noticed additional ones appearing nearby over the following years. This pattern has a name: field cancerization. Chronic UV exposure does not just damage individual cells in isolation. It alters the genetic makeup of skin across an entire region, creating a field of precancerous tissue. Multiple independent tumors can then arise within that field at different times.6PubMed Central. Field cancerization in dermatology
This is why a dermatologist treating a single basal cell carcinoma on your forehead will often examine the rest of your face, scalp, and ears closely. The visible lesion is a signal that the entire zone has sustained enough damage to produce cancer, and siblings may follow. It also explains why some people feel as though skin cancers suddenly start appearing in groups when in reality the underlying damage field was already there.
Fast-Growing Types That Genuinely Seem Sudden
While most skin cancers are slow-moving, several subtypes grow fast enough to justify the impression that they appeared overnight.
Nodular melanoma is the one that worries dermatologists most. Unlike the more common superficial spreading melanoma, which tends to expand outward across the skin surface for months before it invades deeper, nodular melanoma grows vertically from the start. Patients describe these lesions as going from a tiny dot to a raised, dark bump in a matter of weeks. In a qualitative study, patients with thin nodular melanomas reported rapid color changes, from brown to black in a dripping pattern, and the development of vertical growth over as little as two weeks.7PubMed Central. Patient-identified early clinical warning signs of nodular melanoma: a qualitative study Because nodular melanomas do not go through a long, flat, spreading phase, they often get caught at a thicker stage and carry a worse prognosis.
Keratoacanthoma is another lesion famous for alarming speed. It can balloon into a dome-shaped, crater-topped nodule within a few weeks. Some keratoacanthomas will actually shrink on their own over time, but distinguishing them from squamous cell carcinoma is difficult even for experienced clinicians, because both can share overlapping features.8PubMed Central. Keratoacanthoma-Type Invasive Squamous Cell Carcinoma Managed Non-surgically With Topical Immunomodulators9Scholars Journal of Medical Case Reports. Keratoacanthoma Centrifugum Marginatum: A Reported Case Most clinicians treat them as potential squamous cell carcinomas rather than gambling on spontaneous regression.
Merkel cell carcinoma is rarer but grows quickly and can be deadly. It typically presents as a firm, painless, reddish nodule on sun-exposed skin in older adults, and it tends to enlarge rapidly over weeks.10PubMed. Merkel cell carcinoma: Clinical and anatomopathological features, management and survival in our centre Because it does not look like people’s mental image of skin cancer, it is frequently mistaken for a cyst or an insect bite, and the diagnosis gets delayed.
Warning Signs and How to Spot Change
The traditional ABCDE rule (asymmetry, border irregularity, color variation, diameter over six millimeters, and evolution) remains useful for superficial spreading melanoma, the most common type. But a study comparing confirmed melanomas with suspicious-looking benign lesions found that certain features were far more reliably present in the cancerous group: evolution in size, shape, or color within six months; firmness to the touch; rapid growth within six weeks; crusting or oozing; and sensory changes like itching.11PubMed. Clinical Features of Malignant Melanoma of the Skin Versus Suspicious Benign Skin Lesions Evolution, more than any single static feature, is the most consistent marker that something has gone wrong.
The “ugly duckling” sign is another practical screening concept. Instead of evaluating a single mole against a checklist, you compare every mole to its neighbors. Most of your moles tend to look roughly alike in color and pattern. A mole that stands out as different from the rest, the ugly duckling, deserves a closer look. Research has found that teaching patients to use the ugly duckling approach improves their ability to accurately distinguish melanomas from benign lesions, particularly by reducing false alarms while maintaining detection rates.12PubMed. The role of the ugly duckling sign in patient education
For people at high risk, such as those with many atypical moles or a family history of melanoma, total body photography combined with digital dermoscopy offers a way to track every lesion over time. By comparing standardized photos taken months or years apart, clinicians can catch subtle changes that would be invisible in a single office visit.13PubMed Central. The Value of Total Body Photography for the Early Detection of Melanoma: A Systematic Review In a family with an inherited cancer-predisposition syndrome, all three melanomas detected were new atypical lesions spotted through routine total body photography and dermoscopy, none were noticed by the patients themselves first.14PubMed. Familial Melanoma Associated with Li-Fraumeni Syndrome and Atypical Mole Syndrome: Total-body Digital Photography, Dermoscopy and Confocal Microscopy
The Skin Cancers That Do Not Look Like Skin Cancer
Amelanotic melanoma lacks the dark pigment people associate with melanoma. It can appear as a pink, red, or skin-colored bump, and because it does not match anyone’s mental model of a dangerous mole, it tends to be diagnosed later and at a more advanced stage.15PubMed Central. Amelanotic Melanoma: Symptoms, Causes, Treatment If you are checking your skin for dark, irregularly shaped lesions and ignoring anything that is pink or flesh-toned, you will miss this type entirely.
Acral melanoma, which develops on the palms, soles, or under the nails, is another category that slips through the cracks. It occurs in locations most people do not think of as sun-exposed, and its appearance can mimic much more ordinary problems. A case report described a very elderly patient with diabetes whose plantar melanoma was initially treated as a diabetic foot ulcer for an extended period before the correct diagnosis was reached.16PubMed Central. Acral Plantar Melanoma Mimicking a Diabetic Foot Ulcer in a Nonagenarian: A Case Report Another case documented acral nodular melanoma on the heel that showed rapid progression with ulceration and secondary changes over a period of months.17PubMed Central. Acral Nodular Melanoma Presenting With Rapid Progression These are not exotic curiosities. Acral melanoma accounts for a disproportionate share of melanoma in people with darker skin tones, partly because other melanoma types are less common in that population and partly because the soles and nail beds are not areas people routinely examine.
Why Sunburns at Any Age Matter
The old advice that childhood sunburns are the main risk factor for melanoma tells only part of the story. A comprehensive meta-analysis found that sunburns increase melanoma risk regardless of when they happen, whether during childhood, adolescence, or adulthood. When the data were standardized to the same time scale, the association was actually stronger for people who continued getting sunburned at the same rate into adulthood.18PubMed Central. Sunburns and risk of cutaneous melanoma, does age matter: a comprehensive meta-analysis The practical implication is that it is never too late for sun protection to matter. Avoiding burns at fifty is still reducing your melanoma risk, even if you were reckless at fifteen.
Skin color, hair color, mole count, and a history of sunburns are all associated with melanoma risk across body sites.19PubMed Central. Association of Phenotypic Characteristics and UV Radiation Exposure With Risk of Melanoma on Different Body Sites High cumulative UV exposure has been linked more strongly with certain subtypes, including lentigo maligna melanoma and nodular melanoma, than with others.20PubMed Central. Subtypes of Melanomas Associated with Different Degrees of Actinic Elastosis in Conventional Histology, Irrespective of Age and Body Site, Suggesting Chronic Ultraviolet Light Exposure as Driver for Lentigo Maligna Melanoma and Nodular Melanoma So the type of melanoma you develop may partly reflect how your skin has been exposed over your lifetime, not just whether you were exposed at all.
Immunosuppression Speeds Things Up
Organ transplant recipients develop skin cancers at dramatically higher rates than the general population. Part of this is straightforward: the drugs that keep the immune system from rejecting the transplanted organ also reduce the body’s ability to destroy cells that have turned abnormal. But the mechanism goes deeper than just weakened immune surveillance. Certain immunosuppressive drugs, particularly calcineurin inhibitors, directly impair cells’ ability to repair UV-induced DNA damage by reducing the activity of specific DNA repair genes.21PubMed Central. Skin cancer in organ transplant recipients: more than the immune system This means the cells are not just less likely to be caught by the immune system after they mutate; they are more likely to accumulate mutations in the first place. For transplant recipients, aggressive sun protection and frequent dermatologic screening are not optional extras.
Smartphone Apps and AI-Assisted Detection
You may have encountered phone apps that promise to analyze photos of your skin lesions. The technology is real, but the current performance has limits. A prospective study testing an AI-based smartphone application for skin cancer detection found that the system achieved a sensitivity of about 83% and a specificity of about 77% when it could successfully capture the lesion. When AI screening was combined with remote review by a dermatologist, specificity improved to roughly 87%, but sensitivity dropped somewhat.22PubMed. Artificial intelligence-based smartphone application for skin cancer detection: a prospective diagnostic accuracy study The system also performed better at identifying non-melanoma skin cancers than melanocytic lesions, which is somewhat concerning given that melanoma is the type you least want to miss.
These tools are best thought of as a supplement, not a replacement. An app that misses roughly one in five skin cancers is useful as a prompt to see a dermatologist, but it is not reliable enough to provide reassurance that a suspicious spot is safe. If something on your skin is new, growing, or changing, that warrants a clinical evaluation regardless of what any algorithm says. The most promising direction in this space combines AI-assisted analysis with total body photography and digital dermoscopy, creating a longitudinal record that can flag changes too subtle for the human eye to catch in a single snapshot.13PubMed Central. The Value of Total Body Photography for the Early Detection of Melanoma: A Systematic Review
When “Sudden” Actually Means “Suddenly Noticed”
Perhaps the most common misconception about skin cancer is that a spot that was not there last month must have developed last month. In reality, many skin cancers sit at a subclinical or hard-to-see stage for a long time before they cross the visibility threshold. A flat, light-brown melanoma on the back of your thigh could have been slowly widening for a year before it darkened enough to catch your eye in the mirror. The mutation process described earlier, from normal cell to early mutation to driver mutation to visible tumor, plays out over years in the vast majority of cases.
The genuine exceptions are the fast-growing subtypes discussed above. Nodular melanoma, keratoacanthoma-type squamous cell carcinoma, and Merkel cell carcinoma can grow from nearly invisible to alarming within weeks. For these, “sudden” is not an illusion. Any new bump that is growing noticeably over a period of weeks, especially if it is firm, dome-shaped, or has an unusual color, warrants an urgent appointment rather than a wait-and-see approach. The distinction is worth keeping in mind: slow development that is suddenly noticed is the norm, but rapid clinical growth does exist and demands a faster response.